430 related articles for article (PubMed ID: 34406761)
1. Biomedical Applications of a Novel Class of High-Affinity Peptides.
Saw PE; Xu X; Kim S; Jon S
Acc Chem Res; 2021 Sep; 54(18):3576-3592. PubMed ID: 34406761
[TBL] [Abstract][Full Text] [Related]
2. Antibody-Assisted Delivery of a Peptide-Drug Conjugate for Targeted Cancer Therapy.
Kim H; Hwang D; Choi M; Lee S; Kang S; Lee Y; Kim S; Chung J; Jon S
Mol Pharm; 2019 Jan; 16(1):165-172. PubMed ID: 30521347
[TBL] [Abstract][Full Text] [Related]
3. Phage Selection of Cyclic Peptides for Application in Research and Drug Development.
Deyle K; Kong XD; Heinis C
Acc Chem Res; 2017 Aug; 50(8):1866-1874. PubMed ID: 28719188
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging.
Park J; Kim S; Saw PE; Lee IH; Yu MK; Kim M; Lee K; Kim YC; Jeong YY; Jon S
J Control Release; 2012 Oct; 163(2):111-8. PubMed ID: 22964395
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectin.
Kim H; Lee Y; Lee IH; Kim S; Kim D; Saw PE; Lee J; Choi M; Kim YC; Jon S
J Control Release; 2014 Mar; 178():118-24. PubMed ID: 24462899
[TBL] [Abstract][Full Text] [Related]
6. From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker.
Gray BP; Li S; Brown KC
Bioconjug Chem; 2013 Jan; 24(1):85-96. PubMed ID: 23186007
[TBL] [Abstract][Full Text] [Related]
7. Protein catalyzed capture agents with tailored performance for in vitro and in vivo applications.
Coppock MB; Warner CR; Dorsey B; Orlicki JA; Sarkes DA; Lai BT; Pitram SM; Rohde RD; Malette J; Wilson JA; Kearney P; Fang KC; Law SM; Candelario SL; Farrow B; Finch AS; Agnew HD; Heath JR; Stratis-Cullum DN
Biopolymers; 2017 Mar; 108(2):. PubMed ID: 27539157
[TBL] [Abstract][Full Text] [Related]
8. A Hybrid Platform Based on a Bispecific Peptide-Antibody Complex for Targeted Cancer Therapy.
Yu B; Hwang D; Jeon H; Kim H; Lee Y; Keum H; Kim J; Lee DY; Kim Y; Chung J; Jon S
Angew Chem Int Ed Engl; 2019 Feb; 58(7):2005-2010. PubMed ID: 30600870
[TBL] [Abstract][Full Text] [Related]
9. γ-AApeptides: Design, Structure, and Applications.
Shi Y; Teng P; Sang P; She F; Wei L; Cai J
Acc Chem Res; 2016 Mar; 49(3):428-41. PubMed ID: 26900964
[TBL] [Abstract][Full Text] [Related]
10. A high-affinity peptide for nicotinic acetylcholine receptor-α1 and its potential use in pulmonary drug delivery.
Park S; Kim YJ; Jon S
J Control Release; 2014 Oct; 192():141-7. PubMed ID: 25025285
[TBL] [Abstract][Full Text] [Related]
11. Conversion of low-affinity peptides to high-affinity peptide binders by using a β-hairpin scaffold-assisted approach.
Kim S; Kim D; Lee Y; Jeon H; Lee BH; Jon S
Chembiochem; 2015 Jan; 16(1):43-6. PubMed ID: 25371172
[TBL] [Abstract][Full Text] [Related]
12. VEGF-binding aptides and the inhibition of choroidal and retinal neovascularization.
Jo DH; Kim S; Kim D; Kim JH; Jon S; Kim JH
Biomaterials; 2014 Mar; 35(9):3052-9. PubMed ID: 24388818
[TBL] [Abstract][Full Text] [Related]
13. Combining Chemical Protein Synthesis and Random Nonstandard Peptides Integrated Discovery for Modulating Biological Processes.
Saha A; Suga H; Brik A
Acc Chem Res; 2023 Jul; 56(14):1953-1965. PubMed ID: 37312234
[TBL] [Abstract][Full Text] [Related]
14. Homing Peptides for Cancer Therapy.
Lingasamy P; Teesalu T
Adv Exp Med Biol; 2021; 1295():29-48. PubMed ID: 33543454
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth.
Sharma S; Kotamraju VR; Mölder T; Tobi A; Teesalu T; Ruoslahti E
Nano Lett; 2017 Mar; 17(3):1356-1364. PubMed ID: 28178415
[TBL] [Abstract][Full Text] [Related]
16. Human Fibronectin Extra-Domain B (EDB)-Specific Aptide (APTEDB) Radiolabelling with Technetium-99m as a Potent Targeted Tumour-Imaging Agent.
Mohammadgholi M; Sadeghzadeh N; Erfani M; Abediankenari S; Abedi SM; Emrarian I; Jafari N; Behzadi R
Anticancer Agents Med Chem; 2018; 18(2):277-285. PubMed ID: 28925879
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
[TBL] [Abstract][Full Text] [Related]
18. Engineering Persistent Luminescence Nanoparticles for Biological Applications: From Biosensing/Bioimaging to Theranostics.
Sun SK; Wang HF; Yan XP
Acc Chem Res; 2018 May; 51(5):1131-1143. PubMed ID: 29664602
[TBL] [Abstract][Full Text] [Related]
19. Synthetic antibody libraries focused towards peptide ligands.
Cobaugh CW; Almagro JC; Pogson M; Iverson B; Georgiou G
J Mol Biol; 2008 May; 378(3):622-33. PubMed ID: 18384812
[TBL] [Abstract][Full Text] [Related]
20. Targeted Cancer Therapy Using Fusion Protein of TNFα and Tumor-Associated Fibronectin-Specific Aptide.
Jeon H; Kim D; Choi M; Kang S; Kim JY; Kim S; Jon S
Mol Pharm; 2017 Nov; 14(11):3772-3779. PubMed ID: 28969419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
